BI 905711
1412-0001
Phase 1 small_molecule completed
Quick answer
BI 905711 for Gastrointestinal Neoplasms is a Phase 1 program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Gastrointestinal Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed